Overview

The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects

Status:
Unknown status
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
This study is a single-center, randomized, open, double-cycle and double-cross and self-reflection phase Ic clinical trial, to evaluate effect and safety of high fat diet on pharmacokinetics of SPH3127 tablets. Two panels, each consisting of ten participants (The number of single-sex subjects is not less than 1/3 of the total number) will be randomized to A or B groups.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd